PT
Persevere Therapeutics Inc.
SEC filingOther · Chesterbrook, PA
Amount raised$1.6Msold at filing
Total offering$5M$3.4M still open
Investors in the raise12count reported to the SEC
FiledMar 4, 2026first sale Feb 11, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Greg BoschExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.